UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	October 6, 2021

Accession Number:	0001193125-21-292163
Submission Type:	POS AM
CIK: 0001346302 Company Name: XERIS PHARMACEUTICALS INC File Number: 333-233061